Gofen & Glossberg LLC Astrazeneca PLC Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gofen & Glossberg LLC holds 33,965 shares of AZN stock, worth $2.66 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

33,965

Previous 33,908 0.17%

Holding current value

$2.66 Million

Previous $1.86 Million 23.82%

% of portfolio

0.06%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$54.21 - $70.44 $3,089 - $4,015	57 Added 0.17%	33,965 $2.3 Million
Q3 2022 Oct 13, 2022	SELL	$53.02 - $135.75 $20,730 - $53,078	-391 Reduced 1.14%	33,908 $1.86 Million
Q2 2022 Jul 14, 2022	SELL	$59.26 - $71.14 $23,704 - $28,456	-400 Reduced 1.15%	34,299 $2.27 Million
Q1 2022 Apr 14, 2022	SELL	$55.72 - $67.12 $11,812 - $14,229	-212 Reduced 0.61%	34,699 $2.3 Million
Q4 2021 Jan 25, 2022	SELL	$54.02 - $63.83 $150,607 - $177,958	-2,788 Reduced 7.4%	34,911 $2.03 Million
Q3 2021 Oct 13, 2021	BUY	$55.56 - $60.79 $28,335 - $31,002	510 Added 1.37%	37,699 $2.26 Million
Q2 2021 Jul 13, 2021	SELL	$48.42 - $60.18 $108,945 - $135,405	-2,250 Reduced 5.71%	37,189 $2.23 Million
Q4 2020 Jan 15, 2021	BUY	$48.52 - $58.02 $25,181 - $30,112	519 Added 1.33%	39,439 $1.97 Million
Q3 2020 Oct 09, 2020	SELL	$53.07 - $61.1 $10,189 - $11,731	-192 Reduced 0.49%	38,920 $2.13 Million
Q2 2020 Jul 13, 2020	SELL	$43.1 - $55.31 $6,809 - $8,738	-158 Reduced 0.4%	39,112 $2.07 Million
Q1 2020 Apr 14, 2020	SELL	$37.79 - $51.33 $4,345 - $5,902	-115 Reduced 0.29%	39,270 $1.75 Million
Q4 2019 Jan 28, 2020	SELL	$42.46 - $50.46 $4,246 - $5,046	-100 Reduced 0.25%	39,385 $1.96 Million
Q3 2019 Oct 10, 2019	SELL	$40.12 - $45.47 $601 - $682	-15 Reduced 0.04%	39,485 $1.76 Million
Q2 2019 Jul 12, 2019	SELL	$37.28 - $41.68 $22,517 - $25,174	-604 Reduced 1.51%	39,500 $1.63 Million
Q1 2019 Apr 11, 2019	SELL	$35.49 - $43.02 $9,049 - $10,970	-255 Reduced 0.63%	40,104 $1.62 Million
Q4 2018 Jan 15, 2019	SELL	$36.86 - $41.49 $3,686 - $4,149	-100 Reduced 0.25%	40,359 $1.53 Million
Q3 2018 Oct 11, 2018	SELL	$34.76 - $39.72 $12,583 - $14,378	-362 Reduced 0.89%	40,459 $1.6 Million
Q2 2018 Jul 11, 2018	SELL	$34.55 - $37.05 $290,220 - $311,220	-8,400 Reduced 17.07%	40,821 $1.43 Million
Q1 2018 Apr 11, 2018	SELL	$32.97 - $36.63 $143,353 - $159,267	-4,348 Reduced 8.12%	49,221 $1.72 Million
Q4 2017 Jan 11, 2018	SELL	$32.09 - $34.78 $96,270 - $104,340	-3,000 Reduced 5.3%	53,569 $1.86 Million
Q3 2017 Nov 16, 2017	SELL	$28.96 - $34.0 $39,501 - $46,376	-1,364 Reduced 2.35%	56,569 $1.92 Million
Q2 2017 Aug 16, 2017	BUY	N/A	57,933	57,933 $1.98 Million

Others Institutions Holding AZN

# of Institutions

1,332

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $243B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Astrazeneca PLC Transaction History